Patent · US Expired

Imidazopyridine derivatives

US6653320B2 · kind B2 · utility

43Cited by
1References
14Claims
0Family size

Assignees

Inventors

Key dates

Filing dateMar 1, 2002
Grant dateNov 25, 2003
Priority date
Expiry dateMar 1, 2022

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D487/04
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention relates to novel compounds having a phosphatidylinositol 3 kinase (PI3K) inhibiting activity which are useful as medicaments, more particularly as antitumor agent. Novel 3-(imidazo[1,2-a]pyridin-3-yl) derivatives or salts thereof exhibit an excellent PI3K inhibiting activity and cancer cell growth inhibiting activity, and are thus useful as medicaments, especially as PI3K inhibitors and antitumor agents.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.